Providing High-Quality Care to Patients With Kidney Disease
University of Cincinnati Medical Center’s End Stage Renal Disease Center provides all forms of treatments for patients with advanced kidney disease including hemodialysis, peritoneal dialysis, continuous hemofiltration and dialysis (CVVH and CVVHD) and surgical placement of vascular access for hemodialysis and peritoneal catheter for peritoneal dialysis treatment. In addition, apheresis is provided for patients who require plasma exchange for various hematological, neurological and renal diseases.
Our interventional nephrologists use innovative techniques for vascular access procedures, which include declotting grafts; dye studies on grafts, fistulas and catheters; placing tunnel catheters; removing tunnel catheters for dialysis; and placing and removing catheters for peritoneal dialysis. Our inpatient unit provides eight dialysis stations, a separate isolation station and a procedure room with an adjoining recovery area.
Sixteen physicians provide patient care at University of Cincinnati Medical Center’s End Stage Renal Disease Center as well at its network of outlying dialysis units.
Research Brings New Treatments to Patients
Many of our University of Cincinnati Medical Center specialists are currently working as University of Cincinnati researchers and educators and have earned international reputations for their work on kidney disease. Our specialists have received grants from research organizations including the National Institutes of Health, U.S. Department of Veterans Affairs, the American Heart Association and other national organizations to identify the causes of worsening kidney disease. Our goal is to develop new treatments to control the progression of kidney disease and new therapies to sustain dialysis access in patients, eliminating the need for multiple interventions and surgeries. All of our research efforts are focused on significantly improving quality of life for our patients.